SAIDAT OLUWATUYI: Open Payments
NPI 1174226682 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 12 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $150 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $421 |
| Alkermes, Inc. | 2 | $137 |
| Otsuka America Pharmaceutical, Inc. | 1 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: COBENFY, LYBALVI, ABILIFY MAINTENA, CAPLYTA, ARISTADA.
Industry payments across DC — which companies pay providers there.
